Klotho Neurosciences, Inc.
KLTO
$1.54
$0.042.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.71M | -6.15M | -4.21M | -1.39M | -1.21M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.91M | 3.05M | 2.14M | 327.30K | 287.30K |
| Change in Net Operating Assets | -677.10K | 150.60K | -131.30K | -43.80K | 612.80K |
| Cash from Operations | -4.48M | -2.95M | -2.20M | -1.11M | -307.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -123.50K | -23.30K | -79.60K | -89.60K |
| Cash from Investing | 0.00 | -123.50K | -23.30K | -79.60K | -89.60K |
| Total Debt Issued | 4.42M | 2.30M | 1.10M | 950.00K | -- |
| Total Debt Repaid | -120.00K | -120.00K | -- | -- | -- |
| Issuance of Common Stock | 125.00K | 300.00K | 400.00K | 400.00K | 275.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -125.00K | -125.00K | -125.00K | -125.00K | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 713.70K | 778.90K | 898.90K | 770.40K | 0.00 |
| Cash from Financing | 5.01M | 3.13M | 2.27M | 2.00M | 275.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 533.50K | 60.90K | 48.80K | 804.90K | -121.60K |